Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists
Camps-Herrero, C., Paz-Ares, L., Codes, M., López-López, R., Antón-Torres, A., Gascón-Vilaplana, P., Guillem-Porta, V., Carrato, A., Cruz-Hernández, J. J., Caballero-Díaz, C., Blasco-Cordellat, A., Moreno-Nogueira, J. A., Díaz-Rubio, E.
Published in Clinical & translational oncology (01.10.2014)
Published in Clinical & translational oncology (01.10.2014)
Get full text
Journal Article
Final results of the global and Asia cohorts of KAMILLA, a phase IIIB safety trial of trastuzumab emtansine in patients with HER2-positive advanced breast cancer
Wuerstlein, R., Ellis, P., Montemurro, F., Antón Torres, A., Delaloge, S., Zhang, Q., Wang, X., Wang, S., Shao, Z., Li, H., Rachman, A., Vongsaisuwon, M., Liu, H., Fear, S., Peña-Murillo, C., Barrios, C.
Published in ESMO open (01.10.2022)
Published in ESMO open (01.10.2022)
Get full text
Journal Article
Oncologist’s knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study
López López, R., Camps Herrero, C., Khosravi-Shahi, P., Guillem Porta, V., Carrato Mena, A., Garcia-Foncillas, J., Cruz Hernández, J. J., Gascón Vilaplana, P., Antón Torres, A., Diaz-Rubio, E., Feyjoo Saus, M., Aranda Aguilar, E.
Published in Clinical & translational oncology (01.05.2018)
Published in Clinical & translational oncology (01.05.2018)
Get full text
Journal Article
First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN
Martínez-Jañez, N., Ezquerra, M. Bellet, Manso Sanchez, L. M., Carrasco, F. Henao, Torres, A. Anton, Morales, S., Ortega, P. Tolosa, Gil, V. L. Obadia, Sampedro, T., Conejero, R. Andrés, Calvo-Martinez, L., Galve-Calvo, E., López, R., de la Pena, F. Ayala, Lopez-Tarruella, S., de Araguiz, B. A. Hernando Fernandez, Ruiz, L. Boronat, Cardenas, T. Martos, Chacon, J. I., Antón, F. Moreno
Published in Breast cancer research and treatment (01.07.2024)
Published in Breast cancer research and treatment (01.07.2024)
Get full text
Journal Article
5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy
Cervantes, A., Villar-Grimalt, A., Abad, A., Antón-Torres, A., Belón, J., Dorta, J., Tres, A., Camps, C., Fonseca, E., Massutí, B., Aranda, E., Blanco, E., de Paredes, M. García, Hernández, J. J. Sánchez, García-Conde, J., Díaz-Rubio, E.
Published in Annals of oncology (01.11.1993)
Published in Annals of oncology (01.11.1993)
Get full text
Journal Article
Impact of the 21-gene assay on treatment decisions in high-risk patients with ER-positive HER2-negative early breast cancer: Results of the KARMA Dx study
Llombart, A., Andrés, R., Anton Torres, A., Martinez, N., Rodriguez, C., Sánchez-Rovira, P., Rojas, B., Ruiz Borrego, M., Bermejo, B., Martinez de Dueñas, E.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study
Aranda, E., Díaz-Rubio, E., Cervantes, A., Antón-Torres, A., Carrato, A., Massutí, T., Tabernero, J. M., Sastre, J., Trés, A., Aparicio, J., López-Vega, J. M., Barneto, I., García-Conde, J.
Published in Annals of oncology (01.07.1998)
Published in Annals of oncology (01.07.1998)
Get full text
Journal Article
Clinical practice evaluation of opioids induced constipation management in oncologic patients: The EIO-50 project
Salvador Bofill, J., Guillem Porta, V., Feyjoo, M., Anton Torres, A., Aranda Aguilar, E., Camps, C., Carrato Mena, A., Constenla Figueiras, M., Cruz Hernandez, J.J., Diaz Rubio, E., Garcia Foncillas, J., Gascon, P.N., Lopez Lopez, R., Soler, B., Escobar, Y.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
The quality oncology practice initiative program: Experience in Spain
Lopez Lopez, R., Anton Torres, A., Aranda Aguilar, E., Carrato Mena, A., Constenla Figueiras, M., Cruz Hernandez, J.J., Diaz Rubio, E., Feyjoo, M., Garcia Foncillas, J., Gascon, P.N., Guillem Porta, V., Lugo Cuan, I.S., Rogado, A., Camps, C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Psychological distress and health-related quality of life in women recently diagnosed with breast cancer in the Epi-GEICAM study
Fernández-De-Larrea, N., Pérez-Gómez, B., Ruiz, A., Casas, A.M., Bermejo, B., Baena-Cañada, J.M., Antolin, S., Sánchez Rovira, P., Ramos Vázquez, M., Garcia-Saénz, J.A., Anton Torres, A., Muñoz, M., Jara, C., Gil-Gil, M., Adrover, E., Oltra, A., Brunet, J., Bezares, S., Martín, M., Pollán, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
Schneeweiss, A., Peretz-Yablonski, T., Nowecki, Z., Merot, J.-L., Pena-Murillo, C., Bachelot, T., Coudert, B., Nowecki, Z., Wardley, A., Puglisi, F., Montemurro, F., Hu, X., Gaafar, R., Li, H., Aktas, B., Tienghi, A., Miles, D., Lux, M., Menjon Beltran, S., Turner, N., Tong, Z., Boer, K., Horvath, Z., Susnjar, S., Matos, E., Garcia Estevez, L., Cruz, M., Bourgeois, H., von Schumann, R., Morales-Vásques, F., Voitko, N., Hicks, J., Barrett-Lee, P., Wheatley, D., Gozy, M., Latini, L., Barnadas Molins, A., Bratos, R., McCarthy, N., Kee, D., Artignan, X., Azribi, F., Jaafar, H., Augereau, P., Müller, V., Evron, E., Cascinu, S., El-Saghir, N., Ghosn, M., Oosterkamp, H.M., Kukulska, M., Levitt, N., Panwar, U., Rigg, A., Fein, L., Malik, L., Singer, C., Stoeger, H., Cedeño, M., Berdah, J.-F., Goncalves, A., Orfeuvre, H., Fried, G., Moscetti, L., Siddiqi, N., Arcediano Del Amo, A., McAdam, K., Dunn, G., Taylor, W., Hegg, R., Grosjean, J., Laplaige, P., Christensen, B., Zahm, D.-M., Inbar, M., Bonetti, A., van der Velden, A., van Warmerdam, L., Viñas Vilaro, G., Bachmeier, K., Beresford, M., Joffe, J., Nobre, A., Jiang, J., Padrik, P., Dohollou, N., Prulhiere, K., Ober, A., Alabiso, O., van de Wouw, A.J., Saadein, A., Abdelhafiez, N., Abulkhair, O., Llorente Domenech, R., Gil Raga, M., Rodriguez Sanchez, C., Torrego Garcia, J., Vicente Rubio, E., Jones, A., Alonso, I.
Published in Annals of oncology (01.10.2021)
Published in Annals of oncology (01.10.2021)
Get full text
Journal Article
123MO BARBICAN: A randomized, phase II study to determine the contribution of ipatasertib to neoadjuvant chemotherapy plus atezolizumab in women with triple-negative breast cancer
Schmid, P., Bofill, F.J. Salvador, Bermejo, B., Phillips, M., Wheatley, D., Neus, F., Schem, C., Stradella, A., Mele, M., Salgado, A. Cortes, Quiroga, V., Torres, A. Antón, Cussac, A. Llombart, Zamora, E., Viale, G., Kuemmel, S., Prendergast, A., Mousa, K., Gluz, O., Cortés, J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial
Aranda, E., Cervantes, A., Carrato, A., Fern´ndez-Martos, C., Antón-Torres, A., Massutí, T., Barneto, I., García-Conde, J., Barón, J. M, Díaz-Rubio, E.
Published in Annals of oncology (01.08.1996)
Published in Annals of oncology (01.08.1996)
Get full text
Journal Article
Retrospective study of weekly paclitaxel-cetuximab (WPC) in unselected patients (p) with recurrent/metastatic head and neck squamous cell carcinoma (RM-SCCHN)
Bernad, I. Pajares, Trufero, J. Mártinez, Urquizu, L. Calera, de Miguel, A. Cebolleo, Cid, R. Pazo, Valero, M. Lanzuela, Agsustín, M.J., Millastre, E., Lobera, C. Santander, Alejandro, M. Alvarez, Gimeno, N., Yague, M. Malo, Llorente, Y., Torres, A. Antón
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts
Camps Herrero, Carlos, Antón Torres, Antonio, Cruz-Hernández, Juan Jesús, Carrato, Alfredo, Constenla, Manuel, Díaz-Rubio, Eduardo, Feyjoo Saus, Margarita, Garcia-Foncillas, Jesus, Gascón, Pere, Guillem, Vicente
Published in Journal of pain research (01.07.2019)
Published in Journal of pain research (01.07.2019)
Get full text
Journal Article
The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD)
Aranda, E, Cervantes, A, Carrato, A, Antón-Torres, A, Massutí, T, Fernández-Martos, C, Díaz-Rubio, E
Published in The Journal of infusional chemotherapy (1996)
Get more information
Published in The Journal of infusional chemotherapy (1996)
Journal Article
174P Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: Phase IIIb LUCY final analysis
Balmana, J., Fasching, P.A., Delaloge, S., Park, Y.H., Eisen, A., Bourgeois, H., Kemp, Z., Jankowski, T., Sohn, J., Aksoy, S., Timcheva, C.V., Park-Simon, T-W., Anton Torres, A., John, E., Baria, K., Walker, G., Gelmon, K.A.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
LBA19 Event-free survival (EFS) analysis of neoadjuvant taxane/carboplatin with or without atezolizumab followed by an adjuvant anthracycline regimen in high-risk triple negative breast cancer (TNBC): NeoTRIP Michelangelo randomized study
Gianni, L., Huang, C., Egle, D., Bermejo, B., Zamagni, C., Thill, M., Anton Torres, A., Bianchini, G., Sevillano Fernandez, E., Russo, S., Ciruelos, E.M., Greil, R., Semiglazov, V., Colleoni, M.A., Kelly, C.M., Mariani, G., Del Mastro, L., Spezia, R., Ali, H., Viale, G.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
First-line phase II trial of sorafenib (BAY 43–9006) in patients with advanced renal cell carcinoma unsuitable for cytokine treatment
Maroto-Rey, P., Bellmunt, J., Trigo, J. M., Guillem, V., López-Martín, J. A., Carles, J., Antón-Torres, A., Urruticoechea, L.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Trastuzumab plus docetaxel with or without capecitabine as first-line therapy for HER2-positive locally advanced or metastatic breast cancer: a randomised Phase II study
Wardlev, A, Anton-Torres, A, Pivot, X, Morales-Vasquez, F, Zetina, L, de Fatima Dias Gaui, M, Otero Reyes, D, Jassem, J, Button, P, Bell, R
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article